Tech Company Financing Transactions
Astraveus Funding Round
Astraveus secured a $11 million funding round on 10/24/2023. Backers included private investors.
Transaction Overview
Company Name
Announced On
10/24/2023
Transaction Type
Venture Equity
Amount
$11,003,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to advance the development of its Lakhesys � platform.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1, Avenue Claude Vellefaux Hôpital Saint-Louis, Centre MEARY
Paris, 75010
FR
Paris, 75010
FR
Phone
Undisclosed
Website
Email Address
Overview
Astraveus is revolutionizing the field of CGT manufacturing with the Lakhesys� platform, an end-to-end, cell foundry, that uses deep process optimization and single-use, microfluidic bioprocessors to deliver better results with reduced inputs. By removing the need for large-scale infrastructure, reducing costs, and overcoming the logistical challenges typically associated with CGT manufacturing, Astraveus is seeking to transform patient access to these life-changing therapies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jeremie Laurent
Browse more venture capital transactions:
Prev: 10/24/2023: Keyfactor venture capital transaction
Next: 10/24/2023: Qosmosys venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs